Littink Karin W, van Genderen Maria M, Collin Rob W J, Roosing Susanne, de Brouwer Arjan P M, Riemslag Frans C C, Venselaar Hanka, Thiadens Alberta A H J, Hoyng Carel B, Rohrschneider Klaus, den Hollander Anneke I, Cremers Frans P M, van den Born L Ingeborgh
Rotterdam Eye Hospital, Rotterdam, The Netherlands.
Invest Ophthalmol Vis Sci. 2009 May;50(5):2344-50. doi: 10.1167/iovs.08-2553. Epub 2008 Dec 13.
PURPOSE: The purpose of this study was to identify the causative gene defect in two siblings with an uncharacterized cone-rod dysfunction and to describe the clinical characteristics. METHODS: Genome-wide homozygosity mapping, with a 250K SNP-array followed by a search for candidate genes, was performed. The patients underwent ophthalmic examination, including elaborate electroretinography. RESULTS: In a Dutch sib pair, a shared 9-Mb homozygous region was found on 11q13.1-q13.5 that encompasses the CABP4 gene, previously implicated in autosomal recessive incomplete congenital stationary night blindness (CSNB2) in two small families. A novel homozygous p.Arg216X mutation in CABP4 was detected in the sib pair. Quantitative RT-PCR on RNA isolated from patient lymphoblast cells showed no nonsense-mediated degradation of mutant CABP4 mRNA. Clinically, patients presented with reduced visual acuity, photophobia, and abnormal color vision, but they did not experience night blindness. Electroretinograms showed electronegative mixed rod-cone responses and severely reduced cone responses, as in CSNB2. Isolated rod responses, however, were (sub)normal. CONCLUSIONS: A novel homozygous nonsense mutation in CABP4 in two siblings resulted in a phenotype with severely reduced cone function and only negligibly reduced rod function on electroretinography and psychophysical testing. Since these patients and two of three previously described patients do not experience night blindness, the name CSNB2 is confusing for patients as well as clinicians. Therefore, the authors propose to name the phenotype congenital cone-rod synaptic disorder.
目的:本研究旨在确定两名患有未明确特征的视锥 - 视杆功能障碍的兄弟姐妹的致病基因缺陷,并描述其临床特征。 方法:采用全基因组纯合性图谱分析,先用250K单核苷酸多态性(SNP)芯片,随后寻找候选基因。患者接受了眼科检查,包括详细的视网膜电图检查。 结果:在一对荷兰同胞兄妹中,在11q13.1 - q13.5区域发现了一个共享的9兆碱基纯合区域,该区域包含CABP4基因,此前在两个小家族中该基因与常染色体隐性不完全先天性静止性夜盲(CSNB2)有关。在这对同胞兄妹中检测到CABP4基因有一个新的纯合p.Arg216X突变。对从患者淋巴母细胞中分离的RNA进行定量逆转录聚合酶链反应(RT-PCR),结果显示突变的CABP4信使核糖核酸(mRNA)没有无义介导的降解。临床上,患者表现为视力下降、畏光和色觉异常,但未出现夜盲。视网膜电图显示为电阴性的混合视杆 - 视锥反应,视锥反应严重降低,与CSNB2情况相同。然而,单独的视杆反应是(亚)正常的。 结论:两名兄弟姐妹中CABP4基因的一种新的纯合无义突变导致了一种表型,在视网膜电图和心理物理学测试中视锥功能严重降低,视杆功能仅轻微降低。由于这些患者以及之前描述的三名患者中的两名没有夜盲症状,CSNB2这个名称对患者和临床医生来说都容易造成混淆。因此,作者建议将这种表型命名为先天性视锥 - 视杆突触疾病。
Invest Ophthalmol Vis Sci. 2009-5
Invest Ophthalmol Vis Sci. 2006-8
Br J Ophthalmol. 2012-10-25
Ophthalmology. 2013-5-25
Invest Ophthalmol Vis Sci. 2005-6
Invest Ophthalmol Vis Sci. 1998-11
Am J Ophthalmol. 2004-11
Invest Ophthalmol Vis Sci. 2001-6
Mol Biol Rep. 2025-8-12
Int J Mol Sci. 2025-5-28
Ophthalmic Genet. 2024-12
Doc Ophthalmol. 2024-4
Front Mol Neurosci. 2023-4-27
Int J Mol Sci. 2023-3-7